Incyte Corporation INCY

122.92 (1.90) (1.52%) as of 29 Sep
Market cap
$26.1B
P/E
15.4×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
30.67% 30.82% 29.87% 30.39%

+8 more TTM periods

ROA
23.55% 21.88% 20.75% 20.96%
ROIC
60.50% 61.52% 58.55% 52.81%
Return on Tangible Assets
29.73% 30.37% 30.35% 31.80%
Average Days of Receivables
70.57 71.59 72.73 67.94
Free Cash Flow per Share
9.43 7.13 6.81 5.99
Free Cash Flow
1,890.47 1,420.88 1,329.63 1,172.04
Capital Expenditures
(89.24) (95.90) (83.87) (79.37)
Piotroski F-Score
6.00 8.00 9.00 9.00
Other line items
Cash ROIC
17.33% 14.70% 15.15% 15.40%
Accounts Receivable Turnover
5.91 5.72 5.48 5.82
Accounts Payable Turnover
1.75 1.90 1.83 1.94
Inventory Turnover
4.39 4.49 4.65 4.41
Average Days of Payables
212.72 206.83 205.92 184.87
Days of Inventory on Hand
95.61 104.60 99.12 89.73
Tax Rate
(0.18) (0.19) (0.23) (0.25)
Research and Development Expense of Revenue
36.96% 39.71% 39.88% 39.58%
Selling, General and Administrative Expense of Revenue
24.05% 25.72% 26.77% 27.27%
Share Based Compensation of Revenue
4.38% 4.71% 4.85% 5.38%
Interest Coverage
764.90 689.26 623.91 653.65
Operating CF/Net income
1.23 1.06 1.10 1.05
Depreciation/Fixed assets
0.14 0.13 0.13 0.12
Capex/Depreciation
(0.91) (1.01) (0.90) (0.86)
Revenue per Share
29.04 26.89 26.34 24.60
Operating CF per Share
9.88 7.61 7.24 6.40
Capex per Share
(0.45) (0.48) (0.43) (0.41)
Capex to Sales
0.02 0.02 0.02 0.02

Fold the line items

Columns are period end dates